Clinic
Northwest Texas Healthcare System INC
Northwest Texas Healthcare System INC was paid $44.81M by Medicaid between Jan 2018 and Dec 2024, across 164 billing codes. Its largest line is 99284, emergency room visit (serious) — 43% of everything it billed.
33Billing provider infoNORTHWEST TEXAS HEALTHCARE SYSTEM INC
AMARILLO, TX 79106
AMARILLO, TX 79106
33aNPI1467442418assigned 10/21/2005
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$44.81M
24GClaims428,242
24DCodes billed164
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#11 of 320
Median peer was paid$205K
This provider vs. median219×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 569 | $16K | |
| 2019 | 799 | $27K | |
| 2020 | 14,398 | $1.01M | |
| 2021 | 119,535 | $9.82M | |
| 2022 | 123,236 | $13.18M | |
| 2023 | 110,526 | $14.17M | |
| 2024incomplete | 59,179 | $6.59M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 43% | 33,826 | 32,551 | $19.49M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 48,369 | 47,017 | $7.32M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 8,582 | 8,098 | $5.44M |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 5.8% | 7,953 | 828 | $2.59M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.3% | 13,548 | 11,095 | $1.46M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.0% | 16,972 | 16,536 | $892K |
| 59025 | Fetal non-stress test | 1.6% | 2,707 | 2,457 | $701K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.5% | 2,423 | 2,372 | $668K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.2% | 3,742 | 3,651 | $550K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.2% | 3,610 | 3,371 | $533K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.2% | 15,580 | 15,049 | $529K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 17,334 | 16,922 | $380K |
152 more codes
| G0378 | Hospital observation service, per hour | <1% | 301 | $302K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 29,172 | $245K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,601 | $220K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,540 | $196K |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 124 | $193K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,202 | $169K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 1,089 | $129K |
| 80053 | Comprehensive metabolic panel | <1% | 18,505 | $121K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 132 | $116K |
| 90887 | <1% | 1,323 | $109K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 505 | $103K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 548 | $99K |
| 71045 | Radiologic examination, chest; single view | <1% | 6,484 | $97K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 20,590 | $89K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,127 | $84K |
| 0353U | <1% | 1,057 | $75K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 34,556 | $73K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 2,475 | $71K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 352 | $69K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 1,979 | $69K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 830 | $67K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,175 | $65K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 759 | $65K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,172 | $64K |
| 87581 | <1% | 2,439 | $57K | |
| 87486 | <1% | 2,441 | $57K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 786 | $54K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 2,434 | $52K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,434 | $52K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 405 | $49K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 1,920 | $48K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 298 | $45K |
| 36416 | <1% | 1,616 | $43K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,947 | $40K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,355 | $40K |
| 81001 | <1% | 20,826 | $38K | |
| 86850 | <1% | 1,120 | $37K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 3,444 | $36K |
| G0176 | Activity therapy, such as music, dance, art or play therapies not for recreation, related to the care and treatment of patient's disabling mental health problems, per session (45 minutes or more) | <1% | 422 | $35K |
| 86703 | <1% | 2,671 | $33K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,142 | $33K |
| 59430 | <1% | 251 | $29K | |
| 87081 | <1% | 4,050 | $29K | |
| 81025 | <1% | 5,434 | $27K | |
| 87481 | <1% | 790 | $27K | |
| 80050 | General health panel | <1% | 173 | $22K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 832 | $22K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 185 | $20K |
| 87899 | <1% | 2,575 | $19K | |
| 85027 | <1% | 3,216 | $19K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,267 | $18K |
| 80074 | <1% | 555 | $17K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,350 | $16K |
| 76801 | <1% | 164 | $15K | |
| 87653 | <1% | 468 | $15K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,034 | $15K |
| 84702 | <1% | 1,216 | $14K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 684 | $14K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,117 | $14K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,605 | $13K |
| 84030 | <1% | 1,527 | $13K | |
| 86592 | <1% | 2,881 | $11K | |
| 94664 | <1% | 55 | $11K | |
| 80061 | Lipid panel | <1% | 2,048 | $11K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 138 | $10K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,729 | $10K |
| 82962 | <1% | 1,913 | $10K | |
| 76775 | <1% | 99 | $10K | |
| 84484 | <1% | 2,070 | $9K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,710 | $9K |
| 83690 | <1% | 2,395 | $9K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,074 | $8K |
| 90686 | <1% | 459 | $7K | |
| 86762 | <1% | 559 | $7K | |
| G0379 | Direct admission of patient for hospital observation care | <1% | 30 | $7K |
| 83880 | <1% | 659 | $7K | |
| 82950 | <1% | 1,444 | $6K | |
| 90715 | <1% | 40 | $6K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,269 | $5K |
| 86787 | <1% | 380 | $5K | |
| 83735 | <1% | 1,672 | $5K | |
| 82607 | <1% | 841 | $4K | |
| 86900 | <1% | 1,464 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 782 | $4K |
| 85610 | <1% | 2,012 | $4K | |
| 84439 | <1% | 900 | $4K | |
| 87430 | <1% | 318 | $4K | |
| 86901 | <1% | 1,464 | $3K | |
| 85730 | <1% | 1,368 | $3K | |
| 83605 | <1% | 556 | $3K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 525 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 510 | $3K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 138 | $2K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 27 | $2K |
| 86141 | <1% | 459 | $2K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 240 | $2K |
| 84481 | <1% | 151 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 28 | $2K |
| 87077 | <1% | 274 | $2K | |
| 87340 | <1% | 269 | $2K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 272 | $2K |
| 90661 | <1% | 133 | $2K | |
| 82746 | <1% | 320 | $2K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 12 | $1K |
| 82677 | <1% | 70 | $1K | |
| 82043 | <1% | 743 | $1K | |
| 83540 | <1% | 626 | $966.13 | |
| 87210 | <1% | 262 | $957.51 | |
| 82105 | <1% | 70 | $925.17 | |
| 87186 | <1% | 402 | $874.31 | |
| 86336 | <1% | 70 | $860.18 | |
| 81003 | <1% | 738 | $789.93 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 13 | $763.53 |
| 87428 | <1% | 42 | $718.74 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 60 | $659.88 |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 15 | $652.52 |
| 82570 | <1% | 447 | $551.37 | |
| 82951 | <1% | 42 | $498.06 | |
| G0008 | Administration of influenza virus vaccine | <1% | 355 | $462.75 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 75 | $437.03 |
| 84100 | <1% | 179 | $392.37 | |
| 97163 | <1% | 13 | $382.78 | |
| 82728 | <1% | 128 | $381.19 | |
| 74018 | <1% | 13 | $318.60 | |
| 73610 | <1% | 12 | $304.87 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 242 | $296.32 |
| 84436 | <1% | 30 | $268.87 | |
| 87040 | <1% | 77 | $220.36 | |
| 87070 | <1% | 86 | $209.84 | |
| 82952 | <1% | 75 | $187.23 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 68 | $159.16 |
| 73502 | <1% | 13 | $154.61 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 12 | $120.44 |
| 85018 | <1% | 75 | $112.73 | |
| 85014 | <1% | 75 | $112.73 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 93 | $106.33 |
| 85045 | <1% | 24 | $83.17 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 31 | $77.67 |
| 83970 | <1% | 14 | $69.36 | |
| 84145 | <1% | 12 | $68.58 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 12 | $52.05 |
| 85007 | <1% | 13 | $52.04 | |
| 86308 | <1% | 12 | $47.11 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 13 | $40.62 |
| 82248 | <1% | 33 | $28.16 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 60 | $22.40 |
| 87205 | <1% | 14 | $18.94 | |
| A9270 | Non-covered item or service | <1% | 1,426 | $14.11 |
| 85652 | <1% | 15 | $13.62 | |
| J2704 | Injection, propofol, 10 mg | <1% | 139 | $9.64 |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | 0% | 38 | $0.00 |
| 97010 | 0% | 41 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFILTON, STEVE (CFO, SENIOR VP)
| Provider | Location | Paid |
|---|---|---|
| District Hospital Partners L P | Washington, DC | $136.25M |
| Mcallen Hospitals L P | Edinburg, TX | $124.61M |
| Lancaster Hospital Corporation | Palmdale, CA | $108.63M |
| Universal Health Services of Rancho Springs INC | Murrieta, CA | $61.95M |
| Doctors Hospital of Laredo | Laredo, TX | $52.31M |
| Valley Hospital Medical Center | Las Vegas, NV | $47.03M |
| Uhs of Bowling Green LLC | Bowling Green, KY | $41.21M |
| Uhs-Corona INC | Corona, CA | $35.18M |
| Spring Valley Medical Center | Las Vegas, NV | $33.58M |
| Aiken Regional Medical Centers LLC | Aiken, SC | $31.51M |
| Summerlin Hospital Medical Center L L C | Las Vegas, NV | $30.26M |
| Manatee Memorial Hospital L P | Bradenton, FL | $22.33M |
| Desert Springs Hospital | Las Vegas, NV | $22.29M |
| Fort Duncan Medical Center LP | Eagle Pass, TX | $15.80M |
| Psi Pride Institute INC | Eden Prairie, MN | $15.57M |
| Uhs of Fuller INC | S Attleboro, MA | $13.47M |
| Uhs of Texoma, INC | Denison, TX | $12.51M |
| Arbour INC | Boston, MA | $12.36M |
| Wellington Regional Medical Center LLC | Wellington, FL | $10.75M |
| Friends Behavioral Health System, LP | Philadelphia, PA | $9.55M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.